Monitoring cognitive impairment through speech

Winterlight has developed a tablet-based assessment that is fast, objective, and stress-free. By analyzing speech alone, we can detect cognitive impairment associated with dementia and mental illness. Our assessment can be used in life science research, senior care and clinical settings.

Vocal biomarkers for use in clinical trials

Existing neurological assessments are slow, subjective, and difficult to do remotely. Winterlight’s technology can extract speech-based digital biomarkers from short snippets of speech. The Winterlight Assessment is currently used in a dozen clinical trials to track changes and identify treatment responses. We support life science partners throughout their trials for site onboarding, data collection, speech analysis, and results interpretation.

Work with us

Tracking cognitive wellness in senior care

It is challenging to care for seniors with complex medical needs and frequently with cognitive impairments. Combined with your existing health data, we identify seniors at-risk of cognitive or functional decline. Our assessment can help you provide better proactive care at a time when it is most needed to have the greatest impact on the health and happiness of your residents.

Reach us here

Participate in Winterlight studies

We are researching speech patterns in people of all ages to help us build better tools for disease detection and monitoring. This will allow researchers and clinicians to better understand the signs of neurological and psychiatric disease and work towards treatment and cures. We invite you to help us by participating in our research studies.

Tell me more

Developed in partnership with:



What's new

June 4, 2021

Winterlight publishes new research comparing digital speech measures with clinical assessments

New research published in Alzheimer's Research & Therapy examines how automatically computed speech measures correlate with clinical assessments of speech in Alzheimer's Disease and Mild Cognitive Impairment.

Read Read More
April 30, 2021

Winterlight Labs partners with the Digital Medicine Society (DiMe) to drive adoption of digital health resources

Winterlight Labs participates in the Digital Medicine Society's Tour of Duty to develop resources for the adoption of digital measures in clinical research.

Read Read More
April 29, 2021

Winterlight presents new research on speech as an objective measure of anxiety at the SOBP annual conference

Winterlight presented a poster at the SOBP annual conference exploring the use of remote speech assessments to detect signs of anxiety.

Read Read More
April 7, 2021

ISCTM conference features Winterlight research on validation of automated speech assessments

Winterlight labs presented two research posters at the International Society for CNS Clinical Trials and Methodology (ISCTM) virtual annual meeting highlighting validation studies of their automated speech assessment technology.

Read Read More

Get in touch

Mailing Address

Winterlight Labs
46 Hayden St
Suite 400
Toronto
Ontario, Canada
M4Y 1V8

Send us a message